US2003202979A1PendingUtilityA1
Methods for preparing and delivering adjuvant compositions
Priority: Jun 19, 2001Filed: May 1, 2003Published: Oct 30, 2003
Est. expiryJun 19, 2021(expired)· nominal 20-yr term from priority
Inventors:Jay D. Gerber
A61P 43/00A61P 37/04A61K 39/245A61K 2039/543A61K 2039/542A61P 1/04A61K 2039/545A61K 39/12A61K 2039/55511A61K 2039/541A61K 39/39A61K 2039/55555A61K 2039/5254C12N 2710/16734
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for preparing and delivering an adjuvant for vaccines including lecithin and a polymer. The polymer is preferably polyacrylic acid-based and the delivery method involves administering a vaccine, including an antigen and the adjuvant, to a mucosal surface.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method for delivering a vaccine to a human or an animal mucosally comprising: formulating a vaccine comprising an antigen and an adjuvant comprising lecithin and an acrylic polymer; and administering the vaccine to a mucosal surface.
2 . The method of claim 1 wherein the vaccine is administered to a mucosal surface selected from the group consisting of oral cavity, gut, nasal, vaginal and rectal mucosal surfaces.
3 . The method of claim 1 wherein the vaccine is administered to the human or animal by placing the vaccine in a food or a beverage.
4 . The method of claim 3 wherein the vaccine is administered in a food or a beverage composition in a concentration of from about 0.0001-5.0% by weight.
5 . The method of claim 4 wherein the vaccine is administered in a food or a beverage in a concentration of from about 0.01-1.0% by weight.
6 . The method of claim 1 wherein the vaccine is administered in a dosage form selected from the group consisting of tablet, capsule, granule, suspension, solution, suppository, and troche.
7 . The method of claim 6 wherein the vaccine is administered in a concentration of from about 0.0001-5.0% by weight.
8 . The method of claim 1 wherein the vaccine is administered in an injectable formulation.
9 . The method of claim 8 wherein the vaccine is administered in a concentration of from about 0.2-2.0% by weight.
10 . A method for preparing an adjuvant composition comprising: hydrating lecithin and a polymer in saline or water; and mixing the lecithin and polymer to form an adjuvant.
11 . The method of claim 10 wherein the lecithin and the polymer are mixed by placing the lecithin and the polymer in a blender.
12 . The method of claim 10 wherein the lecithin and the polymer are mixed in the presence of surfactants.
13 . A method according to claim 10 further including the step of microwaving or autoclaving the adjuvant.
14 . A method according to claim 1 wherein from about 0.001-10% by weight dry lecithin and from about 0.001-10% by weight polymer are hydrated.
15 . A method according to claim 14 further including the step of adding an antigen.
16 . A method according to claim 15 wherein the antigen is added during the hydration step.
17 . A method according to claim 15 wherein the antigen is added to the adjuvant.Join the waitlist — get patent alerts
Track US2003202979A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.